The exact etiology of VKH is not firmly established, but current theories posit that patients develop T-cell mediated immunity against melanocytes following recovery from an inciting viral environmental factor.

Recent genetic studies have implicated the presence of human leukocyte antigen (HLA) cell surface markers HLA-DRB4, HLA-DRB1-04*05, and HLA-DRB-04*01, as well as non-HLA genes involving lymphocyte regulations in IL-12 production and IL17 production.